KATELIN N VARNSON
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health WEST ST PAUL, MN NPI 1235669490
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health MN Neurocrine BioSciences, Inc. All categories
General Payments — all program years on this page
$131.53
- Category: General Payments
- Program years: PY2021–2022
- Record count: 10
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $105.61 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $105.61 | 8 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Neurocrine BioSciences, Inc. | $24.97 | 2 |
| Alkermes, Inc. | $24.40 | 2 |
| Vanda Pharmaceuticals Inc. | $16.34 | 1 |
| Teva Pharmaceuticals USA, Inc. | $14.39 | 1 |
| Janssen Pharmaceuticals, Inc | $13.76 | 1 |
| Otsuka America Pharmaceutical, Inc. | $11.75 | 1 |
By program year
Records — PY2022 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 886463927 | Janssen Pharmaceuticals, Inc | $13.76 | 01/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 925962065 | Alkermes, Inc. | $12.10 | 03/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 925962067 | Alkermes, Inc. | $12.30 | 07/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 929494103 | Otsuka America Pharmaceutical, Inc. | $11.75 | 05/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 952009235 | Vanda Pharmaceuticals Inc. | $16.34 | 08/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 954697831 | Teva Pharmaceuticals USA, Inc. | $14.39 | 03/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 963402085 | Neurocrine Biosciences, Inc. | $11.91 | 01/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 963402087 | Neurocrine Biosciences, Inc. | $13.06 | 06/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.